Background Cognitive behaviour therapy (CBT) added to specialist medical care (SMC), or graded exercise therapy (GET) added to SMC, are more eff ective in reducing fatigue and improving physical function than both adaptive pacing therapy (APT) plus SMC and SMC alone for chronic fatigue syndrome. We investigate putative treatment mechanisms.
Introduction
Chronic fatigue syndrome, sometimes referred to myalgic encephalomyelitis, is associated with pro found disability.
1,2 Our multicentred randomised con trolled trial, PACE (adaptive Pacing, graded Activity and Cognitive behaviour therapy; a randomised Evaluation), 3, 4 compared specialist medical care (SMC) alone versus SMC with adaptive pacing therapy (APT), cognitive behaviour therapy (CBT), or graded exercise therapy (GET) for chronic fatigue syndrome.
We standardised treatments by the provision of manuals for doctors, therapists, and participants. At least three sessions of SMC were off ered over 52 weeks and 14 hourly therapy sessions were off ered weekly, then fortnightly, up to 24 weeks. A booster therapy session was given at 36 weeks. Specialist doctors gave participants general advice about managing the illness. It was suggested that extremes of activity and rest should be avoided, selfhelp books were suggested, and specifi c pharmacotherapy could be off ered for insomnia, pain, or mood problems.
CBT involves enabling individuals to develop a consistent approach to activity, and is followed by gradual increases in activity. CBT also encourages people to develop healthy sleep patterns and enables them to identify and challenge unhelpful cognitions 5 with the primary aims of reducing fatigue and improving physical function. It is based on a theoretical model, which supposes that unhelpful interpretations of symptoms, fearful beliefs about engaging in activity, and excessive focus on symptoms are central in driving disability and symptom severity. 5 These cognitive responses are associated with unhelpful behavioural patterns, including avoidance of activity or all-or-nothing behaviour-a pattern of excessive resting alternating with pushing too hard or being overactive when well.
GET for chronic fatigue syndrome involves establishing a baseline of consistent activity and regular sleep-wake cycle, then encouraging mutually negotiated increments in the time spent physically active (most commonly walking) follow ed by an incremental increase in the intensity of exercise to a target of 30 min of physical exercise fi ve times a week. It is based on a model of both de-con ditioning (loss of muscle strength and reduced exercise capacity) and avoidance of activity. 6 Both these factors are thought to maintain fatigue and disability. [7] [8] [9] Systematic reviews have suggested that patients with chronic fatigue syndrome are less physically active and have less isometric muscle strength and reduced exercise capacity than healthy controls. 10, 11 CBT and GET in the context of this trial had much in common, but could be diff erentiated. Both involved agreeing an achievable and consistent baseline of activity and then increasing activity, although GET specifi cally focused on physical exercise. CBT addressed unhelpful thoughts but GET did not. CBT and GET were clearly distinguished by independent raters who rated treatment integrity and were masked to the treatment group. 3 APT for chronic fatigue syndrome involved the encouragement of parti cipants to plan activity with a view to avoiding increases in symptoms, and restricting demands and stress. It included specifi c advice not to undertake activities that demanded more than 70% of participants' perceived energy envelopes to establish a baseline of achievable activity, and then increasing as able. 3 It was based on the envelope theory of chronic fatigue syndrome in which the illness is assumed to be entirely physical, with fi xed energy levels. 12 We found that, when added to SMC, CBT and GET had greater success in reducing fatigue and physical disability than did APT or SMC alone. 3 The number of therapy sessions received was similar across groups. However, the SMC-alone group received a median of two more SMC sessions than the therapy supplemented treatment groups. Antidepressant and hypnotic use did not diff er signi fi cantly between groups, either at baseline or at follow-up. The interval between baseline and follow-up was the same for all treatments. There were no important diff erences in safety outcomes between treatment options. Mean diff erences between groups on primary outcomes almost always exceeded predefi ned clinically useful diff erences for CBT and GET when compared with APT and SMC. In all comparisons of the proportions of participants who had either improved or were within normal ranges for these outcomes, CBT and GET were superior to APT or SMC alone. 3 Improvements were moderate in size and therefore outcomes need to be improved further. Identifi cation of the mechanisms of change might explain how eff ective treatments can be further developed, improved, or optimised. The study of mediation might also provide information about the utility of the model on which treatment is based.
We designed the PACE trial to gain perspective on the mechanisms of change through the identifi cation of mediators. To this end, the trial measured a range of putative mediators and outcomes. We aimed to explore whether specifi c putative mediators measured at 0, 12, 24, and 52 weeks changed to a diff erent extent between treatment groups, and to examine whether these factors mediated diff erences in fatigue and physical function in CBT and GET compared with APT and SMC. Based on models of chronic fatigue syndrome and previous fi ndings we postulated that fearful beliefs, in particular fear avoidance beliefs (eg, "I am afraid that I will make my symptoms worse if I exercise"), symptom focusing (eg, "I think a great deal about my symptoms"), catastrophising (eg, "I will never feel right again"), and avoidance behaviour (eg, "I stay in bed to control my symptoms") would mediate change in fatigue and physical function in both CBT and GET. We also postulated that timed walking distance as a measure of exercise tolerance, but also as a more objec tive measure of activity engagement, would mediate change in both outcomes for CBT and GET. Based on the fact that embarrassment avoidance, damage beliefs, self-effi cacy, perception of eff ort, and unhelpful sleep routines are targeted in CBT, these additional processes were also examined. Some empirical evidence exists to support their inclusion. Embarrassment avoidance (eg, "I am embarrassed about my symptoms") and damage beliefs (eg, "Symptoms are a signal that I am damaging myself") have been shown to change with routine CBT and an exploratory latent trait model suggested that the observed partial mediation model generalised to illnessrelated cognitive traits. 13 There is evidence that selfeffi cacy might be an important transdiagnostic mechanism of change. 14, 15 Perception of eff ort with exercise is increased in people with chronic fatigue syndrome and we believed it was likely to change with rehabilitative treatments such as CBT and GET. 16 A poor sleep routine is commonplace in people with chronic fatigue syndrome, 17 and establishing a sleep routine is a focus of CBT and therefore might improve fatigue and disability. Finally, on the basis of previous trials we predicted that anxiety, depression, all-or-nothing behaviour, and fi tness would not mediate treatment outcome either in CBT or GET.
Methods

Study design and participants
Between March 18, 2005 , and Nov 28, 2008, 641 participants aged 18 years or older were recruited from consecutive new outpatients attending six specialist chronic fatigue syndrome clinics in the UK National Health Service. Participants fulfi lled the Oxford criteria for chronic fatigue syndrome, 2 which requires fatigue to be the principal symptom. All participants were medically assessed by the specialist clinic doctors to exclude alternative diagnoses. 4 The West Midlands Multicentre Research Ethics Committee (MREC 02/7/89) approved the original PACE study.
The main results of the trial have been reported elsewhere; 3 561 (88%) received an adequate dose of treatment and ten (2%) were completely lost to follow-up. We did a planned secondary mediation analysis of the PACE trial comparing SMC alone or SMC plus APT with SMC plus CBT and SMC plus GET for patients with chronic fatigue syndrome.
3,4
Description of the generic mediation model
Mediation is a hypothesised causal chain in which a baseline variable R aff ects a post-baseline mediating variable M, which in turn aff ects an outcome variable Y. 18 In the case of a trial such as PACE, R is treatment group, for example CBT compared with APT, and an example mediator and outcome might be fear avoidance and physical function (fi gure 1). If the intervening variable M explains the relation between R and Y (the relation between R and Y is no longer statistically signifi cant when adjusting for M in the model and the estimate for R is essentially equal to zero), then M is a mediator and we have a full mediational model. 19, 20 If the intervening variable only partially explains the relation between R and Y (the M eff ect is statistically signifi cant but R is not equal to zero or still has a signifi cant eff ect on Y after including M in the model) the model is consistent with partial but not full mediation.
19,20
Procedures
The measures, which are described in more detail in the appendix, were all assessed at 0, 12, 24, and 52 weeks after randomisation, and these were described with unadjusted mean profi le plots. For the mediation analysis, we used the 52 week measure of the outcome and the 12 week measure of the putative mediator. The exception was the walk test where the 24 week measure was used as the mediator; the walk test was not done at 12 weeks owing to the anticipated burden for participants. The 12 week measure of the mediator was used to capture change as early as possible and have the maximum possible separation between mediator and outcome measure ments. This temporal separation between the variables was employed to meet the implicit mediation model assumption of ordering of the variables in the causal chain. 18 This ordering is important for rendering causal mediation inferences more plausible.
The primary outcomes were fatigue measured by the Chalder fatigue scale and physical function measured by the physical function subscale of the SF-36. We measured several of the putative mediators using the Cognitive Behavioural Responses Questionnaire (CBRQ); these were fi ve cognitive measures: catastrophising, fear avoidance beliefs, damage beliefs, symptom focusing, and embarrass ment avoidance beliefs, and two behavioural measures: all-or-nothing behaviour and avoid ance or resting behaviour. Other putative mediators were: self-effi cacy, sleep measured using the Jenkins Sleep Scale, anxiety and depression measured using the Hospital Anxiety and Depression Scale (HADS), fi tness and perceived exertion measured using a step test, and walking distance measured using the 6 min walk test.
Statistical analysis
The main outcomes were pro-rated only when there were at most two items missing from the scale. We calculated the mean value of complete item scores and used them in place of missing item values. The mediators were not pro-rated since most with missing data were missing all items. We restricted the main analyses, including regression models, to participants with complete records for all variables considered. We summarised mediators using the mean, SD, and 95% CI for the mean.
We assessed mediation from regressions with the product of coeffi cients method (POC), 18 shown in both equation (below) and path diagram form (fi gure 1), where Y is the outcome, M is the mediator, R is the randomised treatment group, and ε is an error term (other covariates are not shown for simplicity):
The β 1 parameter is the overall eff ect of the treatment on the outcome, referred to as the c pathway in the mediation literature. The mediated (indirect) eff ect is then β 2 multiplied by γ, or a multiplied by b from fi gure 1. The direct eff ect of R on Y in the presence of M is given by β 3 and is called the c' pathway. In addition to the temporal ordering assumption, the usual assumptions are associated with the regressions used in the POC method, including: accurate measurement, linearity, normally distributed residuals, and no omitted variables. 18 The latter assumption has received a great deal of attention in mediation, particularly in clinical trials where, despite randomisation, there could still be confounding of the non-randomised relation between the mediator and outcome (U in fi gure 1). 18, 20, 21 If there are unmeasured variables that aff ect both mediator and outcome, the estimate obtained for this relation might be biased. Although unmeasured confounding cannot 
See Online for appendix be ruled out, adding baseline variables that might be confounders makes a causal interpretation more plausible; further covariates were included in the models to address this. 18, 21 For example, if these variables were confounders, including them will have provided an adjusted and hopefully more accurate estimate, and if they were proxies for unmeasured confounders they might have partially adjusted for the omitted variables as well. The variables were selected for inclusion in models because they were thought to be potential predictors of mediators and outcomes. Age and sex could also be proxies for other variables that were not measured. The original trial stratifi cation factors were included to respect the trial design. The included baseline variables were: centre, Standardised Clinical Interview for DSM-IV (SCID) depression status, 22 London criteria for myalgic encephalomyelitis status, 23 International Criteria for chronic fatigue syndrome status, 1 baseline measure of mediator, baseline measures of both outcomes, baseline work and social adjustment scale, 24 any anxiety disorder as determined using the SCID, age, sex, chronic fatigue syndrome patient group membership, receipt of fi nancial benefi ts, being in dispute regarding fi nancial benefi ts, physical illness attribution, fi bromyalgia status, 25 illness duration, Jenkins Sleep Score, employment status, body-mass index, and physical symptoms (Patient Health Questionnaire-15) score. 26 All these variables were included in all models, except where they were likely to be collinear with the baseline measure of the mediator (ie, SCID depression was omitted in the HADS depression model, and likewise for anxiety). Medication use variables were available, but were not used because these were not theorised to be likely confounders in the context of the large number of other confounders included.
The POC method shares some similarities with two other methods commonly applied to the study of mediation, the Baron-Judd-Kenny causal steps approach and the use of the structural equation model framework. [18] [19] [20] The causal steps approach requires the overall treatment eff ect, or the eff ect of β 1 in model 1, to be signifi cant before proceeding. Similar to others 18, 21 we do not believe this to be necessary. Rather, we suggest examining whether there is an absence of a treatment eff ect on the mediator, an absence of a mediator eff ect on the outcome, or the occurrence of opposing direct and indirect eff ects. The structural equation modelling framework requires some additional assumptions such as multivariate normality.
The mediator models (model 2) had the 12 week postrandomisation measurement of each of the putative mediators as the dependent variable (except for the 6 min walking distance where the 24 week measure was used) and both treatment group (as a three-level dummy variable with either APT or SMC as the reference category) and the potential confounders as covariates. The outcome models had the 52 week post-randomisation measure of each of the outcomes as the dependent variable, with treatment group, the 12 week measure of the putative mediator, and the potential confounders as covariates (model 3). Tests of interaction between treatment and mediator on outcome were all nonsignifi cant, allowing a coeffi cient b to be estimated that was common to all treatments (fi gure 1), improving effi ciency and model stability. We used the statistical signifi cance and magnitude of the model parameters associated with the c and c´ pathways to assess whether mediation was partial or full.
All continuous variables were standardised (each value had the mean of the variable subtracted and was divided by the SD of the variable) so that parameters represented changes in SD units. Results from the mediator models are therefore in SD units of the mediator; results from the outcome models are in SD units of the outcome. The a multiplied by b mediation eff ect here therefore constituted the recommended standardised mediation eff ect in SD units of the outcome, 18 with a bias-corrected bootstrap 95% CI. This allowed for asymmetry of the interval, obtained using bootstrapping with 1000 repetitions. 18, 27 Bootstrap CIs can have incorrect end points; the bias-corrected bootstrap adjusts the interval endpoints by a constant quantifying the approximate median bias of the bootstrap estimate in units of the standard normal distribution. 27 All mediated eff ects were multiplied by 10 to decrease the number of decimal places in fi gures and tables for visualisation purposes. Mediated eff ects have also been expressed as the proportion of the overall eff ect of the treatment on the outcome, in other words (ab / c) × 100. Note that the percent mediated would not be expected to add up to 100% within a given comparison as the mediators have been studied individually and any overlapping eff ects have not yet been examined. Both CBT and GET were compared with APT and SMC. Some mediated eff ects have been compared between CBT and GET using Wald tests of the equality of the two parameter estimates in the mediator models (model 2). The statistical analyses were done using Stata, version 10.
Role of the funding source
The sponsors or funders of the study had no role in study design, data collection, data analysis, data interpretation, writing of the report, or the decision to publish the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
The appendix shows information about data completeness, balance of baseline variables between the treatment groups in the mediation analysis data subset, and diff erences between the people with and without complete data for the mediation analysis. Unadjusted mean profi le plots of the outcomes over time are also presented in the appendix. Plots and summary statistics for the putative mediators (fi gure 2, appendix) show similar patterns to those of the outcomes with greater improvement with CBT and GET, the majority of change occurring during the treatment phase. There was little change between the end of treatment at 24 weeks and follow-up at 52 weeks. There were some exceptions to the general pattern; all-ornothing behaviour decreased to a similar level for APT, CBT, and GET, and fear avoidance improved more in the GET group than for CBT. Figure 3 shows the treatment eff ects of CBT and GET, as compared with APT and SMC, on the putative mediating variables. These eff ects equate to the a path shown in fi gure 1 and are diff erences in mediator SD units between compared treatments. Compared with APT and SMC, both CBT and GET signifi cantly decreased catastrophising, avoidance behaviour, fear avoidance beliefs, and damage beliefs. The strongest eff ects were on fear avoidance beliefs (CBT vs APT -0·64, 95% CI -0·46 to -0·83, GET vs APT -0·98, -0·80 to -1·16), and damage beliefs (CBT vs APT -0·61, -0·43 to -0·78, GET vs APT -0·56, -0·39 to -0·73). GET had a larger eff ect on fear avoidance beliefs than did CBT (p=0·0004). Compared with APT, both CBT and GET decreased symptom focusing, and compared with SMC, the treatments signifi cantly decreased all-or-nothing behaviour and sleep problems, and increased selfeffi cacy. Additionally, CBT also decreased symptom focusing, embarrassment avoidance, and HADS depression as compared with SMC. In both types of comparisons, GET signifi cantly increased the number of metres walked, whereas CBT did not (GET vs APT 0·43, 95% CI 0·25-0·61; GET vs SMC 0·46, 0·28-0·63; CBT vs GET p=0·001). There were no eff ects on HADS anxiety, physical fi tness, or the adjusted perception of eff ort measure (Borg scale). Figure 4 shows the relation between the putative mediators and the outcomes. These eff ects equate to the b path shown in fi gure 1, and are diff erences in outcome SD units for a 1 SD unit change in the mediator. The models show that increases in catastrophising, all-ornothing behaviour, embarrassment avoidance, fear avoidance beliefs, damage beliefs, HADS depression, sleep problems, and adjusted Borg scores (=worsening) were associated with signifi cantly worse fatigue, which means that when treatments reduced these variables, there was a reduction in fatigue. Increases in (=better) scores of self-effi cacy and metres walked were associated with signifi cant decreases in fatigue. The strongest eff ects on fatigue were for metres walked (-0·32, 95% CI -0·20 to -0·44) and embarrassment avoidance (0·27, 0·16-0·38). All of the mediators with the exception of the physical fi tness measure were associated with physical function; and similar to fatigue, these were in the directions expected. The largest eff ects here were for metres walked (0·44, 0·34-0·55) and HADS depression (-0·33, -0·23 to -0·43). Self-effi cacy also had reasonably strong eff ects on both outcomes. Figures 5 and 6 show standardised mediation eff ects (×10) for all mediators and treatment comparisons studied (parameter estimates, CIs, and proportion mediated are shown in appendix). Fear avoidance beliefs had the largest mediated eff ect on both fatigue and physical function for both CBT (fatigue CBT vs APT -1·22, 95% CI -0·52 to -1·97; physical function CBT vs APT 1·54, 0·86 to 2·31) and GET (fatigue GET vs APT -1·86, -0·80 to -2·89; physical function GET vs APT 2·35, 1·35-3·39). This accounted for 51% of the overall eff ect on physical function for GET and 37% for CBT, as compared with APT. The proportions were 61% and 34% for the same comparisons for the fatigue outcome. Damage beliefs also mediated the eff ects of both treatments on both outcomes-the eff ects were the second largest in magnitude of the cognitive mediators for comparisons with APT (fatigue CBT vs APT -0·85, -0·23 to -1·68, GET vs APT -0·78, -0·24 to -1·58; physical function CBT vs APT 1·26, 0·61-2·13, GET vs APT 1·16, 0·57-2·02), with approximately 25-30% of the overall eff ect on both outcomes being accounted for by damage beliefs. Damage beliefs and self-effi cacy were mediators of similar magnitude for the SMC comparisons. For comparisons with APT, self-effi cacy was either a relatively weak or non-signifi cant mediator because it did not change signifi cantly more with either CBT or GET than with APT (fi gure 3). Catastrophising and avoidance behaviour were also signifi cant mediators of treatments for all comparisons and both outcomes, albeit with eff ects of smaller magnitude as compared with fear avoidance (fi gures 5 and 6, appendix). For example, the largest proportion of the overall eff ect explained for catastrophising was 18% for CBT versus APT for the physical function outcome. The number of metres walked (exercise tolerance) was a strong mediator of the eff ect of GET on both outcomes, both for comparisons with APT (fatigue GET vs APT -1·37, -0·76 to -2·21; physical function GET vs APT 1·90, 1·10-2·91) and SMC (fatigue GET vs SMC -1·46, -0·75 to -2·34; physical function GET vs SMC 2·03, 1·16-2·99), with this accounting for approximately 33% of the overall eff ect for the comparisons with APT.
Other mediated eff ects that were statistically signifi cant for both outcomes were embarrassment avoidance for CBT for both comparisons, all-or-nothing behaviour and sleep problems for CBT and GET comparisons to SMC, and depression for CBT versus SMC only. One mediating eff ect was restricted to the outcome of physical function: symptom focusing was a mediator of CBT as compared with both APT and SMC. Figure 7 shows path diagrams for the fear avoidance beliefs mediator. Fear avoidance was a partial rather than a full mediator in both cases. This can be seen by looking at the c' path, or residual direct eff ect of treatment. This path was only non-signifi cant for the GET versus APT comparison for the fatigue outcome, and even so it still diff ers substantially from zero.
The analysis was repeated using the full information maximum-likelihood structural equation modelling framework that required the weaker assumption of data missing at random and allowed for loss selective on covariates and measured outcomes as described in the Methods. 28 The eff ective sample sizes were increased: 613 to 617 for questionnaire measures (up to 96% complete), 534 for fi tness (83% complete), 535 for perceived exertion (Borg, 84% complete), and 595 for walking (93% complete). Results remained essentially unchanged, although some eff ects that were not signifi cant but borderline in the original analysis became signifi cant: walking for CBT versus SMC, symptom focusing for GET versus APT for physical function, and depression for GET versus SMC for fatigue.
Discussion
Our main fi nding was that fear avoidance beliefs were the strongest mediator for both CBT and GET. Fear avoidance beliefs are characterised by fears that activity or exercise will make symptoms worse. Damage beliefs were also important in comparison with APT. Exercise tolerance as measured by the number of metres walked in a fi xed time was a strong mediator of GET alone. Other cognitive and behavioural measures, such as catastrophising and avoidance behaviour, had small but signifi cant mediation eff ects for both of the eff ective treatments aff ecting both outcomes.
The results suggest that GET might be more specifi c in its eff ects than CBT, with two strong mediators, fear avoidance beliefs, and timed walking distance. The increase in exercise tolerance (walking distance) without an increase in exercise capacity (fi tness) might have been facilitated by the mediating eff ect of reduced fear avoidance beliefs.
For CBT, several mediators were implicated with smaller eff ects of similar magnitude, including depres sion for comparisons to SMC. Although we are cautious about over interpreting the role of depression as a mediator, CBT is an evidence-based approach for depres sion that comprises a variety of diff erent procedures including behavioural activation and cog nitive re structuring not dissimilar to CBT for chronic fatigue syndrome.
Fear avoidance beliefs, the strongest mediator, accounted for up to 60% of the overall eff ect, providing evidence for partial mediation. Many of the mediators accounted for much smaller proportions of the overall eff ects, suggesting that in some cases the eff ects of treatment on outcomes might have been mediated through several small eff ects and that some of the overall treatment eff ects were mediated through variables that were not measured.
These fi ndings, which benefi t from temporal separation in mediator and outcome measures, support the preliminary fi ndings of previous studies 9,29-33 of treatment mechanisms in chronic fatigue syndrome (panel). In a trial of CBT compared with relaxation, 29 Deale and colleagues found that avoidance behaviour was a mediator of the eff ect of CBT on physical function cross-sectionally, and a reduction in fearful cognitions was associated with better outcomes. Wiborg and colleagues 30 found that a decrease in focusing on fatigue mediated the eff ect of CBT in one trial, whereas in another trial by the same investigators, 31 the eff ect of therapy was mediated by a decrease in perceived problems with activity and an increase in the sense of control over fatigue. These and other similar studies have relied on cross-sectional data. 6, 8, 9, [29] [30] [31] 33 Consequently, a temporal separation between the mediator and outcomes was missing, making it diffi cult to ascertain the direction of the causal relation. More recently, the Fatigue Intervention by Nurses Evaluation (FINE) trial compared pragmatic rehabilitation with supportive listening or treatment as usual in chronic fatigue syndrome. Pragmatic rehabilitation contained elements of CBT and GET. It involved regular sessions with a health profes sional, and included physiological explanations for symptoms with graded activity, but also ensured that the individual had appropriate rest and relaxation. It was delivered at home, over an 18 week period by specially trained general nurses. The mediation analysis of the FINE trial found that fear avoidance, embarrass ment avoidance, all-or-nothing and avoidance behaviour were cross-sectional mediators of the treatment eff ect, 32 whereas catastrophising and avoidance behaviour measured after treatment (20 weeks after randomisation) were prospective mediators of the eff ect on fatigue at follow-up (70 weeks after randomisation).
Although symptom focusing was found to be a crosssectional mediator of CBT and GET on fatigue in two previous studies, 9,30 it was not a mediator of the eff ect of the pragmatic rehabilitation treatment in the FINE trial. 32 Additionally, symptom focusing was only a weak mediator of the eff ect of CBT on physical function in our study. These dissimilar results could be explained by diff erences in the measurement of symptom focusing, and there might have been subtle but important diff erences in treatment protocols.
We found that fi tness and perception of exertion did not appear to mediate treatment eff ects, but that timed walking distance, assessed for the fi rst time in our study, mediated the eff ect of GET. This suggests that increasing tolerance of physical activity might produce benefi t without improving physical fi tness. These fi ndings are consistent with those of previous studies. 8, 9, 32 A randomised controlled trial of GET for chronic fatigue syndrome 8, 16 found that those who rated themselves as better were no fi tter or stronger than the rest.A second trial of GET also suggested that physical reconditioning was not a mediator of the eff ect of treatment, but that a reduction in symptom focusing and increased exercise tolerance (as assessed by maximum heart rate achieved with exercise) mediated change in mental and physical fatigue. 9 It must be acknowledged, however, that the walking test might not refl ect activity or exercise levels in everyday life and might provide an explanation for why Wiborg and colleagues 33 found no evidence that actometer-measured physical activity mediated the eff ect of CBT.
This mediational analysis strengthens the validity of our theoretical model of CBT and supports the idea that a similar model is valid for GET by confi rming the role of fearful beliefs and avoidance behaviour. The review of beliefs in chronic fatigue syndrome and fi bromyalgia 34 suggested that fear and avoidance of movement were related to poorer outcomes. Our results suggest that fearful beliefs can be changed by directly challenging such beliefs (as in CBT) or by simple behaviour change with a graded approach to the avoided activity (as in GET).
Clinically, the results suggest that therapies focusing more on self-effi cacy and physical activities could have This review concluded that cognitive behaviour therapy (CBT) and graded exercise therapy (GET) were moderately eff ective treatments for chronic fatigue syndrome, and the results of the PACE trial agreed with this. 3 Few papers have been published on mediation of treatment eff ects in chronic fatigue syndrome, so these were found through pre-existing knowledge of publications, reference lists in these publications, and in the course of routine searches for publications in the fi eld using PubMed up to May 28, 2014 . There is an early paper formulating a general model for fatigue in a group of patients with chronic fatigue syndrome. 6 There are also several studies using cross-sectional mediator and outcome data to study either mediation or relations between mediators and outcomes for CBT [29] [30] [31] 33 and for GET. 9, 16 The recent mediation analysis of the FINE trial of pragmatic rehabilitation for chronic fatigue syndrome used longitudinal data to study mediation. 32 In cross-sectional studies, both CBT and GET were found to target cognitive measures such as fear of, and perceived problems with, activity, symptom focusing, and self-effi cacy.
9,29-31 Fitness measures did not mediate the eff ects of the treatments. 9, 33 The FINE trial showed both cognitive (catastrophising) and behavioural (avoidance behaviour) variables to be longitudinal mediators of the relation between pragmatic rehabilitation and fatigue. 32 
Interpretation
We confi rm that fear avoidance beliefs partially mediate the eff ects of CBT and GET on physical function and fatigue outcomes, and that fi tness measures do not appear to mediate the eff ects of either treatment. We have also shown that changes in behaviour (ie, increased walking distance and reduced avoidance behaviour) can transmit the eff ects of treatments to the outcomes, in particular walking distance for GET. We did not fi nd much evidence for symptom focusing as a mediator in this study. These fi ndings from longitudinal data respecting the hypothesised causal ordering of mediators and outcomes are likely more robust than those from past studies using cross-sectional data. Additionally, we identifi ed mediators with strong relations with outcomes; self-effi cacy, and walking distance. If treatments for chronic fatigue syndrome could be refi ned to target these mediators more accurately, they might lead to greater improvements in outcomes.
some of the fi ndings could be due to chance (ie, type 1 errors might have been made). This should be kept in mind when interpreting the fi ndings, in particular for the more exploratory mediators. Finally, in this analysis we focused on single mediators and the eff ects of some of these variables are not likely to be independent. Our forthcoming analysis of multiple mediator eff ects will provide more information on this issue.
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greater eff ects given that these mediators had strong eff ects on the outcomes. For example, therapists delivering CBT could encourage walking, which might enhance the eff ect of CBT and could be more acceptable to patients. Feedback from young people with chronic fatigue syndrome suggested that they liked the behavioural aspects of CBT, but did not like cognitive restructuring. 35 This study has several strengths. The results originate from the largest trial of CBT and GET to date. The study had few drop-outs and adherence to treatment was high. The study of mediation was incorporated at the design stage of PACE, so mediators were measured at midtreatment allowing the study of mediator measurements taken before those of the outcomes. Temporal ordering of variables and the inclusion of many potential confounding variables makes causal inferences about the mediated eff ects more plausible. Both self-report and objective measures were used, and both were found to mediate treatment eff ects, lending credence to the results.
Limitations include the issue of potential residual unmeasured confounding of the mediator to outcome path. However, given that adjustment was made for several potential confounders it seems unlikely that residual confounding could explain the mediation eff ects found, especially for the stronger eff ects. It is possible that variables were measured with error; however, this generally leads to the dampening of eff ects and so would have disguised a variable's mediating eff ect rather than leading to a variable being found to be a mediator in error. This was a complete case analysis, requiring an assumption of missing completely at random. This limitation was a greater concern for the step-test and walk-test mediators, where more data were missing, than for the questionnairebased mediators. However, the results of the full information maximum-likelihood analysis did not diff er greatly from the complete case analysis, suggesting serious missing data biases were unlikely.
In an ideal world, mediators would have been assessed at every session. Given the pattern of change in the mediators was similar to the pattern of change in the outcomes it is possible that the variables were aff ecting each other reciprocally and more measures might have helped clarify this. However, this was prohibitive in this trial because of cost and possible measurement fatigue on the patients' part. Results from longitudinal analyses incorporating all available mediator and outcome measurements will be discussed in future publications. Additionally, we were only able to assess walking at 24 weeks when most of the change in outcomes had occurred. It would have been more convincing as a mediator if walking had been assessed at 12 weeks mid treatment. We did not fi nd evidence of diff ering b paths (relations between the mediators and outcomes) by treatment group, but we might have had limited power to test for these interactions. Given the number of mediators that have been considered it is possible that
